System Formulary Update
Velmanase alfa (Lamzede)
Situation:
Velmanase alfa (Lamzede) 10 mg SDV for injection was approved for addition to the UNC Health System Formulary at the February 2024 System Pharmacy and Therapeutics Committee meeting.
Background:
The following medication was reviewed: Velmanase alfa (Lamzede) 10 mg SDV for injection.
Assessment/Recommendations:
System P&T voted to include the following product from the UNC Health Medication Formulary:
Note: Stock of this formulary product may vary at individual entities
Formulary/Epic Changes will Go-Live on Tuesday, April 30, 2024